InvestSMART

Imricor Medical Systems Inc (ASX: IMR) - Announcements

Current share price for IMR : $1.635 0.085 (4.94%)+

ASX company news and announcements for Imricor Medical Systems Inc (IMR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imricor Medical Systems Inc (IMR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imricor Medical Systems Inc (IMR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imricor Medical Systems Inc (IMR)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$586 Imricor Receives Ethics Approval to Commence VISABL-VT Trial 1 Aug 2023 8:52AM $0.480 $1.635 risen by 240.63%
$586 Imricor Q2 FY23 Quarterley Activities Report and Appendix 4C 27 Jul 2023 10:01AM $0.440 $1.635 risen by 271.59%
$586 Change in substantial holding 20 Jul 2023 9:36AM $0.400 $1.635 risen by 308.75%
$586 Cleansing Notice 20 Jul 2023 9:34AM $0.400 $1.635 risen by 308.75%
$586 Notification regarding unquoted securities - IMR 19 Jul 2023 2:42PM $0.400 $1.635 risen by 308.75%
$586 Application for quotation of securities - IMR 19 Jul 2023 12:02PM $0.400 $1.635 risen by 308.75%
$586 Update on North Dakota Development Fund Loan 19 Jul 2023 11:55AM $0.400 $1.635 risen by 308.75%
$586 Proposed issue of securities - IMR 18 Jul 2023 9:13AM $0.375 $1.635 risen by 336%
$586 Imricor Secures US$1 Million Private Placement 18 Jul 2023 8:59AM $0.375 $1.635 risen by 336%
$586 Notification of cessation of securities - IMR 14 Jul 2023 4:41PM $0.390 $1.635 risen by 319.23%
$586 Notification regarding unquoted securities - IMR 10 Jul 2023 10:04AM $0.450 $1.635 risen by 263.33%
$586 Supplementary Announcement on GEM Global Funding Facility 7 Jul 2023 10:11AM $0.450 $1.635 risen by 263.33%
$586 Proposed issue of securities - IMR 6 Jul 2023 9:41AM $0.370 $1.635 risen by 341.89%
$586 Imricor Secures up to A$30 Million Facility from GEM Global 6 Jul 2023 9:17AM $0.370 $1.635 risen by 341.89%
$586 Imricor Signs Distribution Agreement with FMS 3 Jul 2023 9:10AM $0.330 $1.635 risen by 395.45%
$586 Notification of cessation of securities - IMR 9 Jun 2023 11:34AM $0.300 $1.635 risen by 445%
$586 Appendix 3Y - SW 7 Jun 2023 11:12AM $0.295 $1.635 risen by 454.24%
$586 Notification regarding unquoted securities - IMR 6 Jun 2023 9:36AM $0.320 $1.635 risen by 410.94%
$586 Release from Voluntary Escrow 26 May 2023 10:47AM $0.280 $1.635 risen by 483.93%
$586 Appendix 3Y - PM 24 May 2023 12:12PM $0.280 $1.635 risen by 483.93%
$586 Appendix 3Y - AM 24 May 2023 12:10PM $0.280 $1.635 risen by 483.93%
$586 Appendix 3Y - MT 24 May 2023 12:10PM $0.280 $1.635 risen by 483.93%
$586 Application for quotation of securities - IMR 24 May 2023 12:05PM $0.280 $1.635 risen by 483.93%
$586 Results of Meeting 12 May 2023 2:10PM $0.280 $1.635 risen by 483.93%
$586 Annual Stockholder Meeting Presentation Slides 12 May 2023 8:00AM $0.280 $1.635 risen by 483.93%

276 - 300 of 602 results

Page 12 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.